chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: M
Vaccine: TD
Symptoms: Injection site pain
Clinical narrative: From initial information received on 19Oct04 from the pt regarding an adverse event occurring, it was reported that the 53 yr old male received a dose of TD adult, lot number U1021AA, administered IM in the left arm on 26Jun04. One day later, on 27Jun04, the pt experienced pain at the injection site. He was seen by a physician and heat was applied. At the time of this report, the pt still persists and the pt has not recovered.
Age: 21.0
Sex: M
Vaccine: TD
Symptoms: Decreased appetite, Dizziness, Throat tightness, Tremor, Urinary incontinence
Clinical narrative: From initial information received on 20 OCT 2004 from the patient's mother regarding an adverse event occurring.  It was reported that a 21 year old male patient that had previously been diagnosed with psychosis and also has a past medical history of severe head injuries with encephalopathy, leg injuries and lyme disease received a TD ADS Adult vaccination, lot number not reported, administered in JULY 2002 for a "Lyme bite".  That evening the patient developed "shaking of the head" and complained of feeling his throat was closing and feeling "foggy".  Since the vaccination the patient developed "incontinence" and has had a "loss of appetite".  Reportedly these symptoms persist and the patient was reported as not recovered.
Age: 26.0
Sex: F
Vaccine: TD
Symptoms: Diarrhoea, Dysphagia, Injury, Pharyngeal oedema, Rash
Clinical narrative: From initial information received on 11/16/04 from a registered nurse regarding an adverse event occurring in the USA, it was reported that a 26 year old female patient received a dose of TD ADS ADULT, lot number U1354AA, with an expiration date of August 2006, administered in the right deltoid at 5:45 PM on 11/15/04. Route of administration was not reported. 30-45 minutes after vaccination, the patient developed facial rash and throat swelling. She also developed vomiting and diarrhea, each occurring once. The patient was able to breathe and swallow, but had difficulty swallowing. She was seen by a doctor the following day and was given Solumedrol IM and Zyrtec. The patient was vaccinated due to a dog bite to her right middle finger. She is allergic to both cats and dogs. Reportedly, she took Benadryl when needed. It was also reported that she previously received one or two diphtheria and tetanus vaccines with no reactions reported, but the patient did not know exactly how many doses she has received. Per the reporter, the patient recovered from these events.
Age: 26.0
Sex: F
Vaccine: TD
Symptoms: Vomiting
Clinical narrative: From initial information received on 11/16/04 from a registered nurse regarding an adverse event occurring in the USA, it was reported that a 26 year old female patient received a dose of TD ADS ADULT, lot number U1354AA, with an expiration date of August 2006, administered in the right deltoid at 5:45 PM on 11/15/04. Route of administration was not reported. 30-45 minutes after vaccination, the patient developed facial rash and throat swelling. She also developed vomiting and diarrhea, each occurring once. The patient was able to breathe and swallow, but had difficulty swallowing. She was seen by a doctor the following day and was given Solumedrol IM and Zyrtec. The patient was vaccinated due to a dog bite to her right middle finger. She is allergic to both cats and dogs. Reportedly, she took Benadryl when needed. It was also reported that she previously received one or two diphtheria and tetanus vaccines with no reactions reported, but the patient did not know exactly how many doses she has received. Per the reporter, the patient recovered from these events.
Age: 12.0
Sex: F
Vaccine: MMR, TD
Symptoms: Erythema, Oedema peripheral, Pain, Paraesthesia, Skin exfoliation
Clinical narrative: From initial information received on 15 NOV 2004 from a physician regarding an adverse event occurring in the USA.  It was reported that a 12 year old female patient received TD ADS Adult and MMR.  The routes of administration were not reported.  The next day on 09 OCT 2004 the patient developed swelling, redness, and peeling skin on both hands.  She then developed pain and tingling in both hands with clumsiness.  This progressed to bilateral leg pain with increased sensitivity to the touch.  The patient was hospitalized on 10 NOV 2004.  She had a positive ASO titer which was treated with amoxicillin, does and date of administration not reported.  The physician reported that the patient's condition is improving with physical therapy.  It is unknown if the patient recovered from this event.
Age: 18.0
Sex: M
Vaccine: MEN, TD, MEN, TD
Symptoms: Headache, Vision blurred
Clinical narrative: From initial information received on 26 JUL 2004 from a the patient's brother regarding an adverse event occurring in the USA, it was reported that an 18 year old male patient received a dose of Menomume and a dose of TD ADS Adult administered at 11:00am on 26 JUL 2004.  Approximately 2.5 hours post-vaccination the patient developed blurred vision and a headache.  The patient took advil but the headache persisted.  At the time of this report the patient was going to the emergency room.  His recovery status is unknown.    From additional information received on 30 AUG 2004 from the responsible physician this case has been medically confirmed.  It was reported that this was the patient's first dose of Menomune and it was administered in the right deltoid.  This was the patient's second dose of TD and it was administered in the left deltoid.  The reporter stated that the case was reviewed and that there was no additional information at the time of this report.  The recovery status of the patient was not provided.    From additional information received on 06 OCT 2004 from the reporting physician it was reported that "my last contact with this patient was on 26 JUL 2004.  I have no knowledge of his present situation.  I presume he is in college and doing well since neither he nor his parents have contacted me".  No further information is anticipated, this case is considered closed.
Age: 22.0
Sex: F
Vaccine: TD, YF, TD, YF, TD, YF
Symptoms: Abdominal pain, Diarrhoea, Fatigue, Influenza like illness, Lethargy
Clinical narrative: From initial information received on 02 SEP 2004 from a health care professional it was reported that a 22 year old female patient received her sixth dose of TD ADS ADULT vaccine administered IM in an unspecified site and her first dose of YF administered SQ in an unspecified site at 1:00pm on 30 AUG 2004.  Two days later on 01 SEP 2004 the patient developed flu-like symptoms became letharhic and her left axilla lymph nodes were noted.  The patient recovery status is currently unknown.    From additional information received on 28 SEP 2004 from a health care professional it was reported that the patient's flu-like symptoms consisted on diarrhea, stomach cramping, and fatigue.  She also had are aches.  It was not reported whether the patient recovered.
Age: 22.0
Sex: F
Vaccine: TD, YF, TD, YF, TD, YF
Symptoms: Lymphadenopathy, Pain
Clinical narrative: From initial information received on 02 SEP 2004 from a health care professional it was reported that a 22 year old female patient received her sixth dose of TD ADS ADULT vaccine administered IM in an unspecified site and her first dose of YF administered SQ in an unspecified site at 1:00pm on 30 AUG 2004.  Two days later on 01 SEP 2004 the patient developed flu-like symptoms became letharhic and her left axilla lymph nodes were noted.  The patient recovery status is currently unknown.    From additional information received on 28 SEP 2004 from a health care professional it was reported that the patient's flu-like symptoms consisted on diarrhea, stomach cramping, and fatigue.  She also had are aches.  It was not reported whether the patient recovered.
Age: 22.0
Sex: F
Vaccine: TD, YF, TD, YF, TD, YF
Symptoms: Influenza like illness, Lethargy, Lymphadenopathy
Clinical narrative: From initial information received on 02 SEP 2004 from a health care professional it was reported that a 22 year old female patient received her sixth dose of TD ADS ADULT vaccine administered IM in an unspecified site and her first dose of YF administered SQ in an unspecified site at 1:00pm on 30 AUG 2004.  Two days later on 01 SEP 2004 the patient developed flu-like symptoms became letharhic and her left axilla lymph nodes were noted.  The patient recovery status is currently unknown.    From additional information received on 28 SEP 2004 from a health care professional it was reported that the patient's flu-like symptoms consisted on diarrhea, stomach cramping, and fatigue.  She also had are aches.  It was not reported whether the patient recovered.
Age: 36.0
Sex: M
Vaccine: MEN, TD, MEN, TD
Symptoms: Blister, Rash erythematous
Clinical narrative: Initial information received on 12 OCT 2004 from a health care professional regarding an adverse event in the USA it was reported that a 36 year old male patient received a dose of MENOMUNE, site of administration not reported, as well as a dose of TD ADS Adult, administered in the left deltoid on 08 AUG 2004.  Routes of administration were not reported.  The following day the patient developed patchy and red areas measuring five mm in side on one side of his buttocks bilaterally extending up his torso with approximately 30 in number on his torso.  The red areas were also noted on his left arm and right elbow.  Some of the sites were blistered and opened.  No drainage was noted.  The patient also previously received TWINRIX on 08 SEP 2004 with no reaction reported.  He also received IPOL, TYPHOID, and YELLOW FEVER and MMR on an unspecified date in AUG with no reactions reported.  Lot numbers as well as routes and sites of administration for these vaccines were not reported.  Reportedly the patient did not recover from these events.    From additional information received on 24 JAN 2005 from a registered nurse it was reported that the patient received his firs dose of MENOMUNE in the upper left deltoid and a dose of TD ADS ADULT in the lower left deltoid on 08 OCT 2004.  Per the reporter the patient recovered from these events.  No further information is anticipated, this case is considered closed.
Age: 36.0
Sex: M
Vaccine: MEN, TD, MEN, TD
Symptoms: Erythema, Rash
Clinical narrative: Initial information received on 12 OCT 2004 from a health care professional regarding an adverse event in the USA it was reported that a 36 year old male patient received a dose of MENOMUNE, site of administration not reported, as well as a dose of TD ADS Adult, administered in the left deltoid on 08 AUG 2004.  Routes of administration were not reported.  The following day the patient developed patchy and red areas measuring five mm in side on one side of his buttocks bilaterally extending up his torso with approximately 30 in number on his torso.  The red areas were also noted on his left arm and right elbow.  Some of the sites were blistered and opened.  No drainage was noted.  The patient also previously received TWINRIX on 08 SEP 2004 with no reaction reported.  He also received IPOL, TYPHOID, and YELLOW FEVER and MMR on an unspecified date in AUG with no reactions reported.  Lot numbers as well as routes and sites of administration for these vaccines were not reported.  Reportedly the patient did not recover from these events.    From additional information received on 24 JAN 2005 from a registered nurse it was reported that the patient received his firs dose of MENOMUNE in the upper left deltoid and a dose of TD ADS ADULT in the lower left deltoid on 08 OCT 2004.  Per the reporter the patient recovered from these events.  No further information is anticipated, this case is considered closed.
Age: 22.0
Sex: M
Vaccine: HEP, MMR, TTOX, HEP, MMR, TD
Symptoms: Drug ineffective
Clinical narrative: From initial information received on 08/19/2004 from Glaxosmithkline, from information reported to them by a registered nurse regarding an adverse event occurring in the USA, it was reported that an 11 year old male patient received a tet tox ads usp vaccination, lot number and route and site of administration were not reported, an Engerix-B vaccination, lot number ENG5570A2, manufactured by GSK and administered in the right arm, and a MMR vaccination, lot number not reported, manufactured by Merck, route and site of administration were not reported on 06/16/2004.  It was reported that approximately one day following the administration of Engerix-B, on 06/17/2004, the patient developed rash and hives covering the entire body.  The patient was seen in the emergency room and was treated with Benadryl.  The rash and hives remained unresolved.  On 06/19/2004, the patient was seen again in the emergency room and was treated with Medrol.  The events resolved on 07/02/2004.  The nurse who reported these events considered them to be possibly related to vaccination with Engerix-B.  From additional information received on 10/04/2004 from the initial reporter, additional patient, responsible physician and vaccine information was provided.  The patient received a TD ADS Adult vaccination, lot number U0824AA, administered in the left arm.  The vaccinations were given at 3:00PM.  The adverse events occurred on 06/17/2004 at 7:30PM.  No further information is anticipated, this case is considered closed.
Age: 22.0
Sex: M
Vaccine: HEP, MMR, TTOX, HEP, MMR, TD
Symptoms: Rash
Clinical narrative: From initial information received on 08/19/2004 from Glaxosmithkline, from information reported to them by a registered nurse regarding an adverse event occurring in the USA, it was reported that an 11 year old male patient received a tet tox ads usp vaccination, lot number and route and site of administration were not reported, an Engerix-B vaccination, lot number ENG5570A2, manufactured by GSK and administered in the right arm, and a MMR vaccination, lot number not reported, manufactured by Merck, route and site of administration were not reported on 06/16/2004.  It was reported that approximately one day following the administration of Engerix-B, on 06/17/2004, the patient developed rash and hives covering the entire body.  The patient was seen in the emergency room and was treated with Benadryl.  The rash and hives remained unresolved.  On 06/19/2004, the patient was seen again in the emergency room and was treated with Medrol.  The events resolved on 07/02/2004.  The nurse who reported these events considered them to be possibly related to vaccination with Engerix-B.  From additional information received on 10/04/2004 from the initial reporter, additional patient, responsible physician and vaccine information was provided.  The patient received a TD ADS Adult vaccination, lot number U0824AA, administered in the left arm.  The vaccinations were given at 3:00PM.  The adverse events occurred on 06/17/2004 at 7:30PM.  No further information is anticipated, this case is considered closed.
Sex: M
Vaccine: MMR
Symptoms: Unevaluable event
Clinical narrative: Information has been received from a consumer concerning her son who was vaccinated with measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Subsequently, her son passed away. Medical attention was sought. No product quality complaint involved. No further information is available.
Age: 81.0
Sex: M
Vaccine: PPV
Symptoms: Connective tissue disorder, Dermatitis allergic, Dry skin, Feeling hot, Injection site erythema
Clinical narrative: Information has been received from a registered nurse concerning an 82 year old male with renal failure and on routine dialysis, "maybe" diabetes, unspecified blood pressure disorder and no known drug reactions or allergies. On 20-Oct-2004 the patient was vaccinated with pneumococcal 23v polysaccharide vaccine. At the time of vaccination, the patient was treating with vancomycin and ceftazidime (Fortaz) for an unspecified leg infection. Concomitant therapy included unspecified dialysis medications, unspecified blood pressure medication, unspecified phosphorus binders, and unspecified therapy ("Renajel"), unspecified gastrointestinal preparations (stool softeners), morniflumate (Flomax (morniflumate)), esomeprazole magnesium (Nexium), rosiglitazone maleate (Avandia), furosemide (Lasix (furosemide)), amlodipine besylate (+) benazepril hydrochloride (Lotrel), atorvastatin calcium (Lipitor), an unspecified therapy ("Koreg") and aspirin. On 22-Oct-2004 (onset date of adverse event reported as 20-Oct-2004) the patient presented to his routine dialysis appointment with severe redness, swelling, itching and warmth at the injection site. On 27-Oct-2004 the patient had the same symptoms with the addition of itching. The patient was treated with diphenhydramine hydrochloride (Benadryl) and prednisone. On 29-Oct-2004 the patient developed a rash, fever and chills. At that time the patient was treated with IV cefaxolin sodium (Ancef) and oral levaquin. On 01-Nov-2004 the patient's skin was noted to be "peeling all over his body" and the patient was hospitalized. On 09-Nov-2004, upon discharge from the hospital, the patient was examined by a dermatologist and diagnosed with "acute allergic dermatitis probably secondary to pneumococcol 23v polysaccharide vaccine, resolving with significant xerosis". The patient underwent a skin biopsy of the right forearm which showed solar elastosis and was otherwise unremarkable. As of 23-Nov-2004 the patient was reported to be 90% improved, however, in March 2005 the patient redeveloped a rash. At the time of this report, the outcome of the event was unknown. The nurse considered the acute allergic dermatitis to be an other important medical event. Additional information has been requested. OMIC
Age: 81.0
Sex: M
Vaccine: PPV
Symptoms: Injection site hypersensitivity, Pruritus
Clinical narrative: Information has been received from a registered nurse concerning an 82 year old male with renal failure and on routine dialysis, "maybe" diabetes, unspecified blood pressure disorder and no known drug reactions or allergies. On 20-Oct-2004 the patient was vaccinated with pneumococcal 23v polysaccharide vaccine. At the time of vaccination, the patient was treating with vancomycin and ceftazidime (Fortaz) for an unspecified leg infection. Concomitant therapy included unspecified dialysis medications, unspecified blood pressure medication, unspecified phosphorus binders, and unspecified therapy ("Renajel"), unspecified gastrointestinal preparations (stool softeners), morniflumate (Flomax (morniflumate)), esomeprazole magnesium (Nexium), rosiglitazone maleate (Avandia), furosemide (Lasix (furosemide)), amlodipine besylate (+) benazepril hydrochloride (Lotrel), atorvastatin calcium (Lipitor), an unspecified therapy ("Koreg") and aspirin. On 22-Oct-2004 (onset date of adverse event reported as 20-Oct-2004) the patient presented to his routine dialysis appointment with severe redness, swelling, itching and warmth at the injection site. On 27-Oct-2004 the patient had the same symptoms with the addition of itching. The patient was treated with diphenhydramine hydrochloride (Benadryl) and prednisone. On 29-Oct-2004 the patient developed a rash, fever and chills. At that time the patient was treated with IV cefaxolin sodium (Ancef) and oral levaquin. On 01-Nov-2004 the patient's skin was noted to be "peeling all over his body" and the patient was hospitalized. On 09-Nov-2004, upon discharge from the hospital, the patient was examined by a dermatologist and diagnosed with "acute allergic dermatitis probably secondary to pneumococcol 23v polysaccharide vaccine, resolving with significant xerosis". The patient underwent a skin biopsy of the right forearm which showed solar elastosis and was otherwise unremarkable. As of 23-Nov-2004 the patient was reported to be 90% improved, however, in March 2005 the patient redeveloped a rash. At the time of this report, the outcome of the event was unknown. The nurse considered the acute allergic dermatitis to be an other important medical event. Additional information has been requested. OMIC
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Cough, Face oedema, Urticaria
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male patient with no known allergies and an unknown medical history who on 5/17/05 was vaccinated at the pediatric office at 4:45 PM with a dose of MMR (lot # unknown). Concomitant vaccinations administered at the same time included a dose of poliovirus vaccine, a dose of diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid and tuberculin skin test. On 5/17/05, the patient developed hives, facial swelling, and coughing. It was reported that the patient was taken to the emergency room at 6 PM and was treated with IV diphenhydramine hydrochloride and steroid. The patient was discharged home from the emergency room. The patient recovered on an unspecified date. Hives, facial swelling, and coughing were considered by the reporter, to be immediately life threatening. Additional information has been requested.
Age: 20.0
Sex: F
Vaccine: TD
Symptoms: Asthenia, Hypoaesthesia, Paraesthesia, Viral infection
Clinical narrative: Friday morning 6/3/05 client c/o numbness and tingling left arm. Went to work but numbness in all 4 extremities and neck by noon. Went to hospital. Admitted 6/3/05 and released 6/4/05 afternoon. Client has returned to pre vaccine condition. Information from medical records states viral syndrome, weakness. msv
Age: 41.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Myalgia, Nausea, Pyrexia
Clinical narrative: Patient developed fever up to 103F, approximately 2 hours after receiving Pneumovax.  Myalgia, Nausea/vomiting.  Erythema and swelling at injection site treated with medrol dose pack.
Age: 41.0
Sex: F
Vaccine: PPV
Symptoms: Vomiting
Clinical narrative: Patient developed fever up to 103F, approximately 2 hours after receiving Pneumovax.  Myalgia, Nausea/vomiting.  Erythema and swelling at injection site treated with medrol dose pack.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Injection site induration
Clinical narrative: 6-7cm area of erythema with mild induration on left thigh.
Age: 26.0
Sex: F
Vaccine: TTOX
Symptoms: Lymphadenopathy, Swelling
Clinical narrative: 06/07/2005 Client was given TD vaccine into left deltoid muscle by intramuscular route.  On 06/08/2005 patient called to complain of lymph node swelling in axillae of left arm.  06/10/2005 RS returned to office and no turned clients call.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Blister, Erythema, Feeling hot, Pruritus
Clinical narrative: Approximately 2 hours after DTAP, patient complained of redness and itchiness from 2PM-6PM.  Left arm became increasingly red, warm to touch and hard.  No fever noted.  No Tylenol given or ice applied.  Saw physician on 06/07 for kindergarten PE - noted reaction.  This arm, left arm has oval sized area with multiple small blisters in center of redness.  Advised Tylenol per age and ice pack to area.  To consult with PMD re-blisters. Continues afebrile.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Eye swelling, Swelling
Clinical narrative: 05/25/2005 Grandmother took child to ER for following symptoms:  right arm swollen and red from shoulder to fingers.  Eyes swollen also.  Child given medication.  Brought child to hospital on 05/26, arm swelling decreased but still present.  Child to see Pediatrician.
Age: 1.49
Sex: M
Vaccine: DTAP, IPV, VARCEL
Symptoms: Rash
Clinical narrative: Rash since 06/01/2005 generalized.
Age: 0.34
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Dermatitis contact, Rash vesicular
Clinical narrative: Patient developed diffuse mild vesicular rash on both anterior thighs approximately 10-15 lesions each thigh.  Thought could also be a contact dermatitis secondary to a lotion/topical agent but no specific histy.
Age: 1.02
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Blister, Rash papular
Clinical narrative: Papules and vesicles diffuse.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Erythema, Feeling hot
Clinical narrative: 24 hours after vaccine was given in the right deltoid Mom noticed it was red then the following day arm was warm to touch, had increased redness to the elbow 15x12 cm.  Patient had no complaint of pain only some itching.  MD prescribed Benadryl.  MD felt it was a local reaction.
Age: 1.26
Sex: F
Vaccine: DTAP, HIBV, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site vesicles
Clinical narrative: Localized varicella reaction around injection site redness and swelling around injection site, small blisters around site.  3 small pox like lesions with redness 9 days after shot.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Feeling hot, Hypokinesia, Injection site induration, Swelling
Clinical narrative: Mild induration approximately 8 cm, circumventing right deltoid injection site.  Erythema anterior upper arm shoulder to near elbow.  First noted 06/02/2005 AM.  Arm movement not restricted.  Affected area swollen, warm to touch .  Treatment:  ice compress/elevation/motrin or tylenol.  Will return if temperature develops, symptoms worsen, any lesion develops.
Age: 1.5
Sex: F
Vaccine: DTAP, MMR, VARCEL
Symptoms: Thrombocytopenia
Clinical narrative: Thrombocytopenia, platelet count 80,000, 9 days after shot.
Age: 1.25
Sex: F
Vaccine: MMR, PNC
Symptoms: Pyrexia
Clinical narrative: Fever to 104.5
Age: 1.0
Sex: F
Vaccine: HBHEPB, PNC, VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Broke out in chickenpox lesions 05/26/2005.  Varicella, either Zoster or Varicella.
Age: 0.16
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Feeling hot, Irritability, Musculoskeletal stiffness, Pyrexia
Clinical narrative: Mom states "his arms were flexed for 2-3, he had a high fever but didn't take it just gave Tylenol and he reamianed warmer than normal but I didn't ? or take him to hospital . He was very fussy and irritable. He was  back to normal within 3 days.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Arthralgia, Rash, Rash erythematous, Tremor, Urticaria
Clinical narrative: 2 1/2 days after immunizations, pt got rashes/hives on both thighs some were flush with skin surface others were welts. They didn't disappear until 2 weeks later, 11 days after  immunizations, he c/o severe pain in > Arm and joints. He got the shakes, and vomited. Lasted 1/2 day.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Vomiting
Clinical narrative: 2 1/2 days after immunizations, pt got rashes/hives on both thighs some were flush with skin surface others were welts. They didn't disappear until 2 weeks later, 11 days after  immunizations, he c/o severe pain in > Arm and joints. He got the shakes, and vomited. Lasted 1/2 day.
Age: 1.02
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Skin ulcer, Viral infection
Clinical narrative: 5/13/05 developed 11 chicken pox lesions. Seen according to mom by school nurse; no fever. Spots were on left arm and back.
Age: 40.0
Sex: F
Vaccine: MNQ, TTOX, TYP, YF
Symptoms: Injection site hypersensitivity, Injection site swelling, Injection site warmth, Pruritus, Pyrexia
Clinical narrative: Left arm sub q yellow fever/swollen/itches/redness/hot/site 50/50cirm./fevers/tenderness/
Age: 40.0
Sex: F
Vaccine: MNQ, TTOX, TYP, YF
Symptoms: Tenderness
Clinical narrative: Left arm sub q yellow fever/swollen/itches/redness/hot/site 50/50cirm./fevers/tenderness/
Age: 1.32
Sex: F
Vaccine: DTAP, HIBV, MMR
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Left Upper are red and swollen area 2"x2" AM of 6/9/05, which then extended around shoulder radius of skin. No evidence of infection.
Age: 4.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Injection site swelling
Clinical narrative: Received DTap in L thigh leg swollen no red.
Age: 47.0
Sex: M
Vaccine: MMR, MMR
Symptoms: CSF test abnormal, Diarrhoea, Guillain-Barre syndrome, Muscle atrophy, Muscular weakness
Clinical narrative: Patient received his MMR vaccine on 04/19/05 and admitted to hospital with H/O progressive lower limb and upper right limb. No pain associated with muscle weakness. Patient had H/O dirrhea few days before admission. Patient discharged on 05/25/05 and transferred to rehabilitation center. In hospital, patient diagnosed with Guillain- Barre Syndrome. Spinal tap result: Increased WBC Treatment:Plasmaphoresis Since last week patient developing right upperarm symmetrical atrophy.
Age: 47.0
Sex: M
Vaccine: MMR, MMR
Symptoms: White blood cell count increased
Clinical narrative: Patient received his MMR vaccine on 04/19/05 and admitted to hospital with H/O progressive lower limb and upper right limb. No pain associated with muscle weakness. Patient had H/O dirrhea few days before admission. Patient discharged on 05/25/05 and transferred to rehabilitation center. In hospital, patient diagnosed with Guillain- Barre Syndrome. Spinal tap result: Increased WBC Treatment:Plasmaphoresis Since last week patient developing right upperarm symmetrical atrophy.
Age: 47.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Asthenia, Fatigue, Guillain-Barre syndrome, Hypoaesthesia, Muscle spasms
Clinical narrative: Patient received his MMR vaccine on 04/19/05 and admitted to hospital with H/O progressive lower limb and upper right limb. No pain associated with muscle weakness. Patient had H/O dirrhea few days before admission. Patient discharged on 05/25/05 and transferred to rehabilitation center. In hospital, patient diagnosed with Guillain- Barre Syndrome. Spinal tap result: Increased WBC Treatment:Plasmaphoresis Since last week patient developing right upperarm symmetrical atrophy.
Age: 47.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Nausea, Paralysis, Peripheral coldness, Sleep disorder
Clinical narrative: Patient received his MMR vaccine on 04/19/05 and admitted to hospital with H/O progressive lower limb and upper right limb. No pain associated with muscle weakness. Patient had H/O dirrhea few days before admission. Patient discharged on 05/25/05 and transferred to rehabilitation center. In hospital, patient diagnosed with Guillain- Barre Syndrome. Spinal tap result: Increased WBC Treatment:Plasmaphoresis Since last week patient developing right upperarm symmetrical atrophy.
Age: 36.0
Sex: M
Vaccine: ANTH, FLUX, TYP
Symptoms: Balance disorder, Burning sensation, Condition aggravated, Headache, Hypoaesthesia
Clinical narrative: Localized burning sensation, nausea, vomiting, headaches, insomnia, tremors, numbness on left side of head, balance. Information from 60 day follow-up report states: Currently being treated at hospital. Pt is in a study. Pt had an undetected immunoglobin A deficiency. According to immunologist. The vaccine triggered the deficiency.
Age: 36.0
Sex: M
Vaccine: ANTH, FLUX, TYP
Symptoms: Immunodeficiency, Immunoglobulins decreased, Insomnia, Nausea, Nervous system disorder
Clinical narrative: Localized burning sensation, nausea, vomiting, headaches, insomnia, tremors, numbness on left side of head, balance. Information from 60 day follow-up report states: Currently being treated at hospital. Pt is in a study. Pt had an undetected immunoglobin A deficiency. According to immunologist. The vaccine triggered the deficiency.
Age: 36.0
Sex: M
Vaccine: ANTH, FLUX, TYP
Symptoms: Tremor, Vomiting
Clinical narrative: Localized burning sensation, nausea, vomiting, headaches, insomnia, tremors, numbness on left side of head, balance. Information from 60 day follow-up report states: Currently being treated at hospital. Pt is in a study. Pt had an undetected immunoglobin A deficiency. According to immunologist. The vaccine triggered the deficiency.
Age: 31.0
Sex: M
Vaccine: ANTH
Symptoms: Urticaria
Clinical narrative: Urticaria begining 1-2 days after 3rd Anthrax dose in series. Has had chronic urticaria ever since. No prior h/o urticaria.
Age: 1.05
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Pruritus, Rash papular, Rash vesicular, Rhinorrhoea
Clinical narrative: 4 days after receiving Varivax and MMR broke out in a papular-vesicular rash.  One on ear, two at nape of neck and one on cheek at time of exam. +pruritis.  No fever.  Runny nose day before -resolved today.  No known Varicella exposures.
Age: 1.01
Sex: M
Vaccine: HIBV, MMR, PNC, VARCEL
Symptoms: Medication error
Clinical narrative: HIB was given that was incorrectly mixed with sterile water instead of the normal saline which is provided.  No adverse effect was noted.  MD notified patient's parent to have child re-immunizied.
Age: 25.0
Sex: F
Vaccine: HEP
Symptoms: Anxiety, Heart rate increased, Hyperventilation, Somnolence
Clinical narrative: Several episodes of hyperventilation and anxiety 1 1/4 hrs after injection, requiring paramedic transport to ER. Patient was able to gain control of respiration about 30 seconds or so after each episode, but a few minutes later, cycle would begin again. In ER,given Valium, observed several hours, taken home by co-workers to rest the remainder of that day.  Had minor "sleepiness" after first vaccination on 05/03/05, but worked.  Has been under stress, was wearing "clean room garb" (dust mask, gown).  Was receiving series of Hep B vaccine at work Health Services as a service for volunteering for the onsite Emergency Response Team.  Visit to ER covered under work comp, will see doctor for discharge next week.  Has had no further symptoms after leaving ER.  Able to return to regular work the next day.
Age: 0.5
Sex: M
Vaccine: HIBV, PNC
Symptoms: Medication error
Clinical narrative: HIB was given that was incorrectly mixed with sterile water instead of the normal saline which is provided.  No adverse effect was noted.  MD notified patient's parent to have child re-immunizied.
Age: 42.0
Sex: F
Vaccine: TD
Symptoms: Erythema, Feeling hot, Oedema peripheral, Pyrexia
Clinical narrative: 24 hours, swollen 1/2 way down her arm, warm red. Fever to 101.6  wbc 6.5 Ice applied and Ibuprofen. Swelling went down and fever resolved 1 day later.
Age: 76.0
Sex: F
Vaccine: TD
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site swelling, Pruritus
Clinical narrative: Swelling, redness, and itching on the site of injection.
Age: 2.0
Sex: M
Vaccine: DTAP
Symptoms: Contusion, Hyperhidrosis, Injection site mass, Injection site pain
Clinical narrative: Lots of soreness at the site of injection, some excessive sweating, large bump and slight bruise.  All symptoms started 8-10 hours after injection and continued for 48 hours.  Pain reduction medication (Motrin) was needed.
Age: 1.86
Sex: F
Vaccine: DTAPHEPBIP, HIBV, MMR, VARCEL
Symptoms: Erythema, Pruritus, Rash macular
Clinical narrative: Within 24hrs, itching scalp, red itchy blotches on cheeks; small (quarter sized) bumpy itchy patches on upper right arm, several "pock marks" on different body parts -- still scratching scalp, face spots at 48hrs.  Entries on which shot/which leg and manufacturer is taken from shot record which is handwritten and difficult to read - technician used initials only.
Age: 17.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Fatigue, Lymphadenopathy, Malaise, Medication error, Pain
Clinical narrative: Menactra given improperly subcutaneously, lower area of right upper arm.  Immediate pain with raised red rash rapidly developing and increasing in diameter to three inches by three days, with axillary pain with adenopathy and fever.  Rash and axillary pain resolved after one week, however persistent daily temps. 99.5 to 100.1 continue now with general malaise and extreme fatigue.  No improvement with initial Keflex and later Medrol treatment.  Menomune had been given previously 5/04 without incident.
Age: 17.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Pyrexia, Rash, Rash erythematous
Clinical narrative: Menactra given improperly subcutaneously, lower area of right upper arm.  Immediate pain with raised red rash rapidly developing and increasing in diameter to three inches by three days, with axillary pain with adenopathy and fever.  Rash and axillary pain resolved after one week, however persistent daily temps. 99.5 to 100.1 continue now with general malaise and extreme fatigue.  No improvement with initial Keflex and later Medrol treatment.  Menomune had been given previously 5/04 without incident.
Age: 17.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Cellulitis, Chills, Lymphadenopathy, Malaise, Medication error
Clinical narrative: Menactra given improperly subcutaneously, lower area of right upper arm.  Immediate pain with raised red rash rapidly developing and increasing in diameter to three inches by three days, with axillary pain with adenopathy and fever.  Rash and axillary pain resolved after one week, however persistent daily temps. 99.5 to 100.1 continue now with general malaise and extreme fatigue.  No improvement with initial Keflex and later Medrol treatment.  Menomune had been given previously 5/04 without incident.
Age: 17.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Pain, Pyrexia
Clinical narrative: Menactra given improperly subcutaneously, lower area of right upper arm.  Immediate pain with raised red rash rapidly developing and increasing in diameter to three inches by three days, with axillary pain with adenopathy and fever.  Rash and axillary pain resolved after one week, however persistent daily temps. 99.5 to 100.1 continue now with general malaise and extreme fatigue.  No improvement with initial Keflex and later Medrol treatment.  Menomune had been given previously 5/04 without incident.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Apnoea, Cyanosis, Pulse absent
Clinical narrative: On the morning of 6/9/2005, patient was found in his crib apneic and without pulse.  Resuscitation attempts were unsuccessful and the child was pronounced dead in the Emergency Room. Additional co start from Discharge summary rec'd 06/13/2005 -- cyanosis.
Age: 11.0
Sex: F
Vaccine: UNK
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Swelling and redness at injection site.
Age: 0.32
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Agitation, Decreased appetite, Pyrexia
Clinical narrative: Fever 102 F, extreme irritability- x 24 to 48 hours and poor feeding.
Age: 1.01
Sex: M
Vaccine: DTAPH, MMR
Symptoms: Rash
Clinical narrative: Started with one spot on chin then 2-3 spots appeared. Spots now scabbed over. No TX.
Age: 2.0
Sex: M
Vaccine: DTAP, HIBV, MMR
Symptoms: Dyspnoea, Rash erythematous, Syncope
Clinical narrative: Vaccines administered ( DTaP, IPV,MMR) in late AM. Parents called approximately 2-2 1/2 hours later reporting child developing red, raised spots all over, difficultly breathing, "almost passing out". Ambulance called for transport to ER. ER TX with Benadryl IM and steroid PO and pt recovered completely. DX: hives.
Age: 0.54
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Injection site hypersensitivity
Clinical narrative: Left leg approximately 2cm, red, swollen, unsure of fever.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site oedema, Injection site warmth, Oedema peripheral
Clinical narrative: Left arm swollen, red, and hot.
Age: 1.2
Sex: F
Vaccine: DTAP, HIBV, MMR, PNC, VARCEL
Symptoms: Erythema induratum, Injection site hypersensitivity
Clinical narrative: RXN of erythema/ induction on both right and left thigh. Varicella and MMR inj. site.
Age: 0.38
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Pyrexia
Clinical narrative: Child developed seizure 2 hours after receiving vaccine high fever. Seen at local ER. Child should have no long term sequelae.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Hypokinesia, Injection site oedema, Oedema peripheral
Clinical narrative: Swelling of entire left thigh, pain with ambulation
Age: 1.34
Sex: F
Vaccine: HIBV, MMR, PNC
Symptoms: Eye movement disorder, Febrile convulsion, Postictal state, Pyrexia, Tremor
Clinical narrative: Fever day of vaccinations 102.7 ( after shots) 8:00PM, started shaking- mother thought she was cold. Gave Tylenol for fever 11:18 PM- eyes rolled back in head, shaking, vomiting, temp 103.8 F called 911, took to ER .
Age: 1.34
Sex: F
Vaccine: HIBV, MMR, PNC
Symptoms: Vomiting
Clinical narrative: Fever day of vaccinations 102.7 ( after shots) 8:00PM, started shaking- mother thought she was cold. Gave Tylenol for fever 11:18 PM- eyes rolled back in head, shaking, vomiting, temp 103.8 F called 911, took to ER .
Age: 0.15
Sex: F
Vaccine: DTAP, HBHEPB, HIBV, IPV
Symptoms: Medication error, Overdose, Wrong drug administered
Clinical narrative: Pt received Comvax and Hib at the same time. Comvax is Hib and Hep B together. This was pt 2nd Hep B and 1st Hib- Therfore pt received 2 Hib vaccines- NO reaction as of 24 hours after vaccination.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Hypersensitivity, Oedema
Clinical narrative: Pt has swollen and red right arm deltoid area down to elbow.
Age: 2.0
Sex: F
Vaccine: HIBV, IPV, PNC, TD
Symptoms: Medication error, Wrong drug administered
Clinical narrative: Pt was given adult  Td spoke with pt mom  06/08/08, bilateral leg soreness. No anagesics needed.
Age: 2.0
Sex: F
Vaccine: HIBV, IPV, PNC, TD
Symptoms: Injection site pain, Medication error, Overdose, Wrong drug administered
Clinical narrative: Pt was given adult Td spoke with mom 06/08/05- soreness, bilateral to legs, no analgesics needed.
Age: 43.0
Sex: F
Vaccine: TD
Symptoms: Cellulitis, Injection site erythema, Injection site oedema, Injection site reaction, Pyrexia
Clinical narrative: From initial information received on 31Jan05 from a health care professional regarding an adverse event occurring, it was reported that a 43 yr old female pt received a booster dose of Decavac, lot number U1212DA, admin IM in the left arm on 27Jun05. The following day, on 28Jan05, the pt developed a fever of 104 degrees F, as well as redness and swelling at the injection site. She notified the physician's office on 29Jan04 and was seen in the ER that night. She was treated with oral Keflex and Unisyn intravenously. She was admitted to the hospital the next day with the diagnosis of cellulitis. At the time of this report, the pt had not recovered from these events.
Age: 43.0
Sex: F
Vaccine: TTOX
Symptoms: Lymphadenopathy, Pain
Clinical narrative: From initial information received on 19/mar/2004 from a registered nurse regarding an adverse event occurring in the U.S.A., it was reported that a 43-year-old female patient received a dose of TD ADS ADULT, lot number U1022AA, administered in the left deltoid on 12/mar/2004. An unspecified time later, the patient developed pain in her left deltoid and could not lay on the arm. The patient was seen by a physician on17/Mar/2004 and 18/Mar/2004. She was not sure whether the arm was red, warm or swollen. The patient also developed a lump on her neck. Reportedly, some information will be available at future date in approximately one week. It is unknown when the patient received her last Td booster. The patient's recovery status was not reported. From additional information received from a health care professional,it was reported that the patient fully recovered from these events. No other new medical information was provided. Further information is not anticipated, this case is considered closed. The reporter of this case is the same reporter of case 200401155.
Age: 63.0
Sex: F
Vaccine: TD
Symptoms: Chills, Erythema, Hyperhidrosis, Joint range of motion decreased, Pyrexia
Clinical narrative: From initial information received on 19/Mar/2004 from a registered nurse regarding an adverse event occurring in the U.S.A., it was reported that a 63-year-old female patient received a dose of TD ADS ADULT, lot number U1022AA, administered in the left deltoid on 17/Mar/2004 (route of administration was not provided). That same day, the patient felt feverish with chills and sweats. The following day, she developed swelling, redness and decrease range of motion (location unspecified). The patient's recovery status was not reported. It is unknown when did the patient receive her last Td booster. From additional information received on 12/Aug/2004 from a health care professional, it was reported that the patient completely recovered from these events. No other new medical information was provided. The reporter of this case is the same reporter of case 20040154.
Age: 63.0
Sex: F
Vaccine: TD
Symptoms: Swelling
Clinical narrative: From initial information received on 19/Mar/2004 from a registered nurse regarding an adverse event occurring in the U.S.A., it was reported that a 63-year-old female patient received a dose of TD ADS ADULT, lot number U1022AA, administered in the left deltoid on 17/Mar/2004 (route of administration was not provided). That same day, the patient felt feverish with chills and sweats. The following day, she developed swelling, redness and decrease range of motion (location unspecified). The patient's recovery status was not reported. It is unknown when did the patient receive her last Td booster. From additional information received on 12/Aug/2004 from a health care professional, it was reported that the patient completely recovered from these events. No other new medical information was provided. The reporter of this case is the same reporter of case 20040154.
Age: 57.0
Sex: F
Vaccine: TD
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: From initial information received on 4/15/04 from a HC professional regarding an adverse event occurring in the USA it was reported that a 56 year old female pt received a TD ADS ADULT vaccination, administered in the LA on 04/07/04. approximately 15 minutes post injection, the  pt complained of numbness and tingling from the injection site to her hand. As of 04/15/04 the numbness in her hand was still persistent.
Age: 24.0
Sex: F
Vaccine: TD
Symptoms: Cellulitis, Injection site oedema, Injection site pain, Tenderness
Clinical narrative: From initial information received on 05/11/04 from a physician regarding an adverse event occurring in the USA, It was reported that a 24 year old female pt received a TD ADS ADULT vaccination administered IM in the LA on 05/06/04. Approximately 8 hours later the same day, she experienced pain for 2-5 hours and 5 hours later the area began to swell up and became sensitive. On 05/07/2004 she had a large swollen tender but soft area, cellulitis was suspected and the pt was being followed. The recovery status of the pt was not reported., From additional information received on 08/20/04 from the responsible physician, it was reported that the pt recovered without medication in 5-6 days. The pt received her last dose of TD ADS Adult 3-5 years before and had no previous rxn. Additional lab information was also provided. No further information is anticipated, this case is considered closed. .The reporter of this case is the same reporter of case 200401857.
Age: 42.0
Sex: F
Vaccine: TD
Symptoms: Blister, Cellulitis, Pain, Pyrexia, Swelling
Clinical narrative: From initial information received on 11 MAY 2004 from a physician regarding an adverse event occurring in the USA, it was reported that a 43 year old female patient received a TD ADS Adult vaccination administered IM in the left deltoid on 03 MAY 2004.  The same day the patient developed pain and swelling to which she applied a gel freeze pack.  She also developed a little area of blisters with a lot of tenderness, redness and swelling over a period of a couple of days; and low grade temperature.  She was seen in a walk-in clinic on 07 MAY 2004 and was being followed for cellulitis.  The patient's recovery status was not reported.    From additional information received on 20 AUG 2004 from the responsible physician it was reported that the patient recovered with Levaquin and Erythomycin in five to six days.  She received thsi dose of TD ADS Adult as a booster and had no previous reaction in the past.  The patient's illness at the time of vaccination were reported as well as her allergies.  Additional lab information was also provided.  No further information is anticipated this case is considered closed.  The reporter of this case is the same reporter as case 200401856